regadenoson anhydrous - Medications

Browse 5 medications containing regadenoson anhydrous. Open a product record to review formulation details, related brands, manufacturers, and label-backed information.

Regadenoson REGADENOSON
0.4 mg/5 ml Injection
INTERNATIONAL MEDICATION SYSTEMS, LIMITED FDA Rx Only

Regadenoson is an A 2A adenosine receptor agonist that is a coronary vasodilator [ see Clinical Pharmacology ( 12.1 ) ]. Regadenoson is chemically described as adenosine, 2-[4-[(methylamino)carbonyl]-1H-pyrazol-1-yl]-. Its structural formula is: The molecular formula for regadenoson is C 15 H 18 N 8 O 5 and its molecular weight is 390.35. Regadenoson Injection is a sterile, nonpyrogenic solution for intravenous injection. The solution is clear and colorless. Each 1 mL in the 5 mL pre-filled syringe contains 0.08 mg regadenoson on an anhydrous basis, 10.9 mg dibasic sodium phosphate dihydrate or 8.7 mg dibasic sodium phosphate anhydrous, 5.4 mg monobasic sodium phosphate monohydrate, 150 mg propylene glycol, 1 mg edetate disodium dihydrate, and Water for Injection, with pH between 6.3 and 7.7. structure

Regadenoson REGADENOSON
0.4 mg/5 ml Injection
HOSPIRA, INC. FDA Rx Only

Regadenoson is an A 2A adenosine receptor agonist that is a coronary vasodilator [see Clinical Pharmacology (12.1) ] . Regadenoson is chemically described as adenosine, 2- [ 4- [ (methylamino)carbonyl ] -1 H -pyrazol-1-yl ] . Its structural formula is: The molecular formula for regadenoson is C 15 H 18 N 8 O 5 and its molecular weight is 390.35. Regadenoson injection is a sterile, nonpyrogenic solution for intravenous injection. The solution is clear and colorless. Each 1 mL in the 5 mL pre-filled syringe contains 0.08 mg regadenoson anhydrous, 8.7 mg dibasic sodium phosphate anhydrous, 5.4 mg monobasic sodium phosphate monohydrate, 150 mg propylene glycol, 1 mg edetate disodium dihydrate, and Water for Injection, with pH between 6.3 and 7.7. Chemical Structure

Regadenoson REGADENOSON ANHYDROUS
GE HEALTHCARE INC. FDA Rx Only

Regadenoson is an A 2A adenosine receptor agonist that is a coronary vasodilator [see Clinical Pharmacology (12.1) ] . Regadenoson is chemically described as adenosine, 2-[4- [(methylamino)carbonyl]-1 H -pyrazol-1-yl]. Its structural formula is: The molecular formula for regadenoson is C 15 H 18 N 8 O 5 and its molecular weight is 390.35. Regadenoson injection is a sterile, nonpyrogenic solution for intravenous injection. The solution is clear and colorless. Each 1 mL in the 5 mL pre-filled syringe contains 0.08 mg regadenoson on an anhydrous basis, 21.93 mg dibasic sodium phosphate dodecahydrate, 6.11 mg monobasic sodium phosphate dihydrate, 150 mg propylene glycol, 1 mg edetate disodium dihydrate, and water for injection, with pH between 6.3 and 7.7. Chemical Structure

Regadenoson REGADENOSON
0.4 mg/5 ml Injection
HIKMA PHARMACEUTICALS USA INC. FDA Rx Only

Regadenoson is an A 2A adenosine receptor agonist that is a coronary vasodilator [ see Clinical Pharmacology (12.1) ]. Regadenoson is chemically described as adenosine, 2-[4- [(methylamino)carbonyl]-1 H -pyrazol-1-yl]-, monohydrate. Its structural formula is: Regadenoson Structural Formula The molecular formula for regadenoson is C 15 H 18 N 8 O 5 • H 2 O and its molecular weight is 408.37. Regadenoson injection is a sterile, nonpyrogenic solution for intravenous injection. The solution is clear and colorless. Each 1 mL in the 5 mL pre-filled syringe contains 0.08 mg regadenoson on an anhydrous basis, 10.9 mg dibasic sodium phosphate dihydrate or 8.7 mg dibasic sodium phosphate anhydrous, 5.4 mg monobasic sodium phosphate monohydrate, 150 mg propylene glycol, 1 mg edetate disodium dihydrate, and Water for Injection, with pH between 6.3 and 7.7. Regadenoson Structural Formula

Regadenoson REGADENOSON
0.4 mg/5 ml Injection
DR. REDDY'S LABORATORIES INC. FDA Rx Only

Regadenoson is an A 2A adenosine receptor agonist that is a coronary vasodilator [see Clinical Pharmacology ( 12.1 ) ]. Regadenoson is chemically described as adenosine, 2-[4-[(methylamino)carbonyl]-1 H -pyrazol-1-yl].Its structural formula is: The molecular formula for regadenoson is C 15 H 18 N 8 O 5 and its molecular weight is 390.35. Regadenoson is a sterile, nonpyrogenic solution for intravenous injection. The solution is clear and colorless. Each 1 mL in the 5 mL pre-filled syringe contains 0.08 mg regadenoson on an anhydrous basis, 10.9 mg dibasic sodium phosphate dihydrate, 5.4 mg monobasic sodium phosphate monohydrate, 150 mg propylene glycol, 1 mg edetate disodium dihydrate, and Water for Injection, with pH between 6.3 and 7.7.

About regadenoson anhydrous

This collection groups medications in our database that include regadenoson anhydrous. It currently includes 5 matching listings. Open a result to review formulation details, related brands, manufacturers, and product labels.

What You Can Review

Use this page to find products that share the same indexed ingredient name, then open drug detail pages for dosage, labeling, and related navigation.

Safety Information

Always consult with a qualified healthcare provider before starting, stopping, or changing any medication. The information provided on this page is for educational purposes only and does not constitute medical advice.

Medical Tools & Resources

← Back to search